InsidersTradesSigma
Follow the 중앙백신 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 중앙백신 has logged 4 insider filings. Market capitalisation: €85.1bn. The latest transaction was filed on 15 June 2026 (Purchase). Among the most active insiders: 윤인중. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Central Vaccine 是一家专注于医疗保健和制药领域的公司，在 XKRX 市场上市。它致力于疫苗的开发和生产。